• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

FDA EXPANDS CLEARANCE FOR CANDELA LASER

The U.S. Food and Drug Administration (FDA) has given expanded wrinkle clearance to Candela Corp. for its Smoothbeam diode laser, which can be used for non-invasive treatment of facial wrinkles.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
Related Content
Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MD
May 23rd 2025

Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MD

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness
May 23rd 2025

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness

Suicide Risk Management Crucial in Dermatological Care
May 22nd 2025

Suicide Risk Management Crucial in Dermatological Care

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
May 20th 2025

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor

Quoin Receives FDA Clearance for Second Netherton Trial
May 22nd 2025

Quoin Receives FDA Clearance for Second Netherton Trial

Real-World Data on the Adverse Effects of Apremilast and Deucravacitinib for Psoriasis
May 22nd 2025

Real-World Data on the Adverse Effects of Apremilast and Deucravacitinib for Psoriasis

© 2025 MJH Life Sciences

All rights reserved.